Medications for Chronic Graftversushost Disease

3 results

  • jakafi - ruxolitinib tablet

    (Ruxolitinib)
    Incyte Corporation
    Jakafi treats intermediate or high-risk myelofibrosis and polycythemia vera (in adults intolerant of or unresponsive to hydroxyurea). Also indicated for steroid-refractory acute and chronic graft-versus-host disease in adults and pediatric patients 12 and older.
    Medication Details
    Drug Interactions

  • niktimvo - axatilimab - csfr injection

    (Axatilimab-Csfr)
    Incyte Corporation
    Niktimvo treats chronic graft-versus-host disease (cGVHD) in adults and pediatric patients weighing at least 40 kg, after at least two prior systemic therapies have failed.
    Medication Details
    Drug Interactions

  • rezurock - belumosudil tablet

    (Belumosudil)
    Kadmon Pharmaceuticals, Llc
    Rezurock treats chronic graft-versus-host disease (chronic GVHD) in adults and pediatric patients 12 years and older whose condition has not responded to at least two prior systemic therapies.
    Medication Details
    Drug Interactions